Search details
1.
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.
J Allergy Clin Immunol
; 151(1): 172-181, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36195170
2.
Population pharmacokinetic and exposure-response modelling to inform upadacitinib dose selection in adolescent and adult patients with atopic dermatitis.
Br J Clin Pharmacol
; 89(10): 3139-3151, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37232215
3.
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.
J Allergy Clin Immunol
; 149(3): 977-987.e14, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34403658
4.
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 397(10290): 2169-2181, 2021 06 05.
Article
in English
| MEDLINE | ID: mdl-34023009
5.
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
Lancet
; 397(10290): 2151-2168, 2021 06 05.
Article
in English
| MEDLINE | ID: mdl-34023008
6.
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
Lancet
; 394(10214): 2108-2117, 2019 12 07.
Article
in English
| MEDLINE | ID: mdl-31732180
7.
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.
Blood
; 131(17): 1910-1919, 2018 04 26.
Article
in English
| MEDLINE | ID: mdl-29437592
8.
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
Br J Haematol
; 182(4): 504-512, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29873072
9.
Multidrug-Resistant Campylobacter jejuni Outbreak Linked to Puppy Exposure - United States, 2016-2018.
MMWR Morb Mortal Wkly Rep
; 67(37): 1032-1035, 2018 Sep 21.
Article
in English
| MEDLINE | ID: mdl-30235182
10.
Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease.
Proc Natl Acad Sci U S A
; 112(10): 3044-9, 2015 Mar 10.
Article
in English
| MEDLINE | ID: mdl-25713364
11.
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
N Engl J Med
; 371(3): 213-23, 2014 Jul 17.
Article
in English
| MEDLINE | ID: mdl-24881631
12.
Tracing Origins of the Salmonella Bareilly Strain Causing a Food-borne Outbreak in the United States.
J Infect Dis
; 213(4): 502-8, 2016 Feb 15.
Article
in English
| MEDLINE | ID: mdl-25995194
13.
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
Lancet Oncol
; 17(10): 1409-1418, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27637985
14.
Fungal infections associated with contaminated methylprednisolone injections.
N Engl J Med
; 369(17): 1598-609, 2013 Oct 24.
Article
in English
| MEDLINE | ID: mdl-23252499
15.
Outbreak of Salmonella Newport infections linked to cucumbers--United States, 2014.
MMWR Morb Mortal Wkly Rep
; 64(6): 144-7, 2015 Feb 20.
Article
in English
| MEDLINE | ID: mdl-25695319
16.
Concurrent transmission of multiple carbapenemases in a long-term acute-care hospital.
Infect Control Hosp Epidemiol
; 45(3): 292-301, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38196201
17.
Campylobacter jejuni infections associated with unpasteurized milk--multiple States, 2012.
Clin Infect Dis
; 57(2): 263-6, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23575199
18.
Notes from the Field: Verona Integron-Encoded Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa Outbreak in a Long-Term Acute Care Hospital - Orange County, Florida, 2017.
MMWR Morb Mortal Wkly Rep
; 67(21): 611-612, 2018 Jun 01.
Article
in English
| MEDLINE | ID: mdl-29851944
19.
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis.
JAAD Int
; 6: 27-36, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34988493
20.
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension.
Arthritis Rheumatol
; 74(1): 70-80, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34196498